NICE breast cancer referral criteria miss up to 95% of women under 50 at risk

A new study from the University of Cambridge and the Institute of Cancer Research has found that the current National Institute for Health and Care Excellence (NICE) criteria used by general practitioners to decide who should be referred for further breast‑cancer risk assessment and specialist care miss up to 95 % of women under 50 who will develop the disease within the next decade. The research, which analysed large population datasets, shows that the existing referral thresholds are far too restrictive for younger women, leaving a vast majority of those at genuine risk without early specialist evaluation.

The investigators argue that the NICE guidelines, designed to balance resource use with clinical benefit, inadvertently exclude a group that could benefit most from early intervention. They call for a review of the criteria to incorporate more sensitive risk‑prediction tools and to broaden referral pathways for women under 50. If the guidelines were updated, the study suggests, it could enable earlier detection and treatment, potentially reducing breast‑cancer mortality in this high‑risk cohort.